|
|
|
xtalks.com, webinar
Wednesday, April 06, 2022 | 9am EDT (NA) / 2pm BST (UK) / 3pm CEST (EU-Central)
Who Should Attend?Members of the pharmaceutical industry interested in solubility enhancement and/or 505(b)(2) product development, including: - Formulation Scientists
- R&D/Technology Managers
- Chemistry, Manufacturing and Controls (CMC) Managers
- Business Development Professionals (New Chemical Entities [NCEs] and 505(b)(2)s)
- Strategic Alliance/Partnership Managers
What You Will LearnRegister for this webinar to learn: - Solubility and bioavailability enhancement techniques for BCS Class II and IV APIs
- How oral-grade Apinovex™ Polymers enable stable, amorphous solid dispersions with up to 80% drug loading
- How injectable-grade Apisolex™ Polymers can increase solubility by up to 50,000 times where other excipients fail
- Case study data comparing Apinovex and Apisolex polymers to other solubility-enhancing excipients
- The use of novel excipients to enable IP protection and 505(b)(2) products
|
|
|
|
|
|
Organized by:
|
|
xtalks.com |
|
Invited Speakers:
|
|
SpeakersNick DiFranco, Global Market Segment Manager for Oral Treatments, Lubrizol Life Science HealthNick DiFranco, MEM, is the Global Market Segment Manager for Oral Treatments at Lubrizol Life Science Health (LLS Health). In his role, Nick coordinates a multi-disciplinary team offering excipients and services for controlled release and solubility enhancement in oral solids and liquids, including Carbopol® and Apinovex™ polymers. Prior to this role, Nick held positions as an Applications Scientist and Market Manager at Lubrizol supporting long-acting drug delivery and CDMO services. Nick holds a BS in Biomedical Engineering (Biomaterials focus) and a Master of Engineering and Management degree from Case Western Reserve University. Message PresenterJoey Glassco, Senior Global Market Manager for Parenteral Drug Delivery, Lubrizol Life Science HealthJoey Glassco, MBA, is the Senior Global Market Manager for Parenteral Drug Delivery at Lubrizol Life Science Health (LLS Health). Joey has served as Marketing Director for CDMO division since 2017 and has been involved in pharmaceutical excipient new business development since 2013. Prior to joining the LLS Health, she spent nearly 15 years in marketing roles in various Lubrizol business units. Joey also has over 10 years of experience in finance at Lubrizol, Ford Motor Company, and The Franklin Mint. She received Bachelor of Science degrees in Finance and Accounting from Juniata College and her MBA from the Smeal College of Business at Pennsylvania State University. Message PresenterLiliana Miinea, Technology Manager for Pharmaceutical Excipients, Lubrizol Life Science HealthLiliana Miinea, PhD, is a Technology Manager at Lubrizol Life Science Health (LLS Health). Her work focuses on developing new technologies for pharmaceutical applications mainly in the area of controlled release, drug solubility enhancement and enhanced mucosal delivery. She has over 20 years of experience in developing and characterizing ingredients including nanomaterials, polymer/nanomaterials composites, and novel excipients. Prior to Lubrizol she worked at Avantor Inc., NJ and conducted postdoctoral research at Washington University in St. Louis, and Center for Nanomaterials Research at Dartmouth College, USA. Liliana holds a PhD in Chemistry from the University of Houston, TX.
|
|
|
|
|
|
Deadline for Abstracts:
|
|
na
|
|
|
|
|
|
Registration:
|
|
https://xtalks.com/webinars/novel-solubility-enhancing-excipients-for-oral-and-injectable-drug-products/
|
|
E-mail:
|
|
shunte@xtalks.com
|
|
|
|
|
|
|
|